The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice

Health and Quality of Life Outcomes

Volumn 10, Issue , 2012, Pages

  García Campayo, Javier ^a   Zamorano, Enric ^b   Ruiz, Miguel A ^c   Pérez Páramo, María ^d   López Gómez, Vanessa ^d   Rejas, Javier ^d  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b Primary Care Centre Sant Antoni de Vilamajor   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d PFIZER INC   (United States)

Author keywords

GAD 2; Generalised anxiety disorder; Primary care; Psychometric validity; Screening

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DSM-IV; FEASIBILITY STUDY; FEMALE; GENERALISED ANXIETY DISORDERS SCALE; GENERALISED ANXIETY DISORDERS SCALE 2; GENERALIZED ANXIETY DISORDER; HOSPITAL ANXIETY DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SENSITIVITY AND SPECIFICITY; SPAIN; VALIDATION STUDY; WORLD HEALTH ORGANISATION DISABILITY ASSESSMENT SCALE II;

ACCULTURATION; ADULT; ANXIETY DISORDERS; CLINICAL PROTOCOLS; CROSS-SECTIONAL STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PSYCHOMETRICS; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF-ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOCIAL CLASS; SPAIN; TRANSLATING;

EID: 84866284170     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-10-114     Document Type: Article

References (42)

1. Andlin-Sobocki P, Wittchen HU. Cost of affective disorders in Europe. Eur J Neurol 2005, 12:34-43. 10.1111/j.1468-1331.2005.01195.x, 15877776.
2. The ESEMeD/MHEDEA 2000 investigators Prevalence of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatr Scand 2004, 109:21-27. The ESEMeD/MHEDEA 2000 investigators.
3. Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007, 146:317-325.
4. Wittchen HU. Generalized anxiety disorder: Prevalence, burden, and cost to society. Depress Anxiety 2002, 16:162-171. 10.1002/da.10065, 12497648.
5. Lobo A. Campos R Los trastornos de ansiedad en atención primaria 1997, Madrid, EMISA.
6. Goldberg D, Lecrubier Y. Form and frequency of mental disorders across centres. Mental illness in general health care: An international study. TB Üstün and N Sartorius 1995, John Wiley & Sons on behalf of WHO, Chichester.
7. Chocrón Bentata L, Vilalta Franch J, Legazpi Rodríguez I, Auquer K, Franch L. Prevalencia de Psicopatología en un centro de atención primaria. Aten Primaria 1995, 16:586-590.
8. Kessler D, Lloyd K, Lewis G, Gray DP. Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. Br Med J 1999, 318:436-439.
9. Zimmerman M, Mattia JI. A self-report scale to help make psychiatric diagnoses: the psychiatric diagnostic screening questionnaire. Arch Gen Psychiatry 2001, 58:787-794. 10.1001/archpsyc.58.8.787, 11483146.
10. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Publishing Inc, Washington DC, American Psychiatric Association.
11. Andrews G, Hobbs MJ, Borkovec TD, Beesdo K, Craske MG, Heimberg RG, Rapee RM, Ruscio AM, Stanley MA. Generalized worry disorder: a review of DSM-IV generalized anxiety disorder and options for DSM-V. Depress Anxiety 2010, .
12. World Health Organization The ICD-10 Classification of mental and behavioral disorders. Clinical descriptions and diagnostic guidelines 1992, WHO, Geneva, World Health Organization.
13. Mahe V, Valgo A. Long-term pharmacological treatment of generalized anxiety disorder. Int Clin Psychopharmacol 2000, 15:99-105. 10.1097/00004850-200015020-00006, 10759341.
14. Judd LL, Kessler RC, Paulus MP, Zeller PV, Wittchen HU, Kunovac JL. Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS). Acta Psychiatr Scan 1998, 393:6-11.
15. Stein D. Comorbidity in generalized anxiety disorder: impact and implications. J Clin Psychiatry 2001, 62:29-36.
16. Hamilton M. Diagnosis and Rating of Anxiety. Br J Psychiat Spec. Publ 1969, 3:76-79.
17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370. 10.1111/j.1600-0447.1983.tb09716.x, 6880820.
18. Lipman RS, Covi L. Outpatient treatment of neurotic depression: medication and group psychotherapy. Evaluation of Psychological Therapies 1976, 178-218. Johns Hopkins University Press, Baltimore, MD, Spitzer R, Klein D.
19. Snaith RP, et al. The clinical anxiety scale: an instrument derived from the Hamilton anxiety scale. Br J Psychiatry 1982, 141:518-523. 10.1192/bjp.141.5.518, 7150890.
20. Spielberger CD, et al. Manual for the State-Trait Inventory 1970, Consulting Psychological Press, Palo Alto.
21. Newman M, Zuellig AR, Kachin KE, Constantino MJ, Przeworski A, Erickson T, Cashman-Mcgrath L. Preliminary reliability and validity of the generalized anxiety disorder questionnaire-iv: a revised self-report diagnostic measure of generalized anxiety disorder. Behav Ther 2002, 33:215-233.
22. Kessler RC, Andrews G, Mroczek D, Ustun B, Wittchen HU. The world health organization composite international diagnostic interview short-form (CIDI-SF). Int J Methods Psychiatr Res 1998, 7:171-185.
23. Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder. Arch Intern Med 2006, 166:1092-1097. 10.1001/archinte.166.10.1092, 16717171.
24. García-Campayo JM, Zamorano E, Ruiz MA, Pardo A, Pérez-Páramo M, López-Gómez V, Freire O, Rejas J. Cultural adaptation into spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes 2010, 8:8. 10.1186/1477-7525-8-8, 2831043, 20089179.
25. Donker T, van Straten A, Marks I, Cuijpers P. Quick and easy self-rating of generalized anxiety disorder: validity of the dutch web-based GAD-7, GAD-2 and GAD-SI. Psychiatry Res 2011, 188:58-64. 10.1016/j.psychres.2011.01.016, 21339006.
26. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993, 46:1417-1432. 10.1016/0895-4356(93)90142-N, 8263569.
27. Ruiz MA, Rejas J. Calidad de vida y otras medidas de salud informadas por el paciente. Farmacoeconomía e investigación de resultados en salud: principios y práctica 2002, 115-160. Real Academia Nacional de Farmacia, , Domínguez EA, Madrid SJ.
28. a ed.) 1995, McGraw-Hill, México.
29. Rovienelli RJ, Hambleton RK. On the use of content specialists in the assessment of criterion-referenced test item validity. Tijdschrift voor Onderwijsresearch 1977, 1977:49-60.
30. Vázquez-Barquero JL, Vázquez Bourgón E, Herrera Castañedo S, Saiz J, et al. Spanish version of the new World Health Organization Disability Assessment Schedule II (WHO-DAS-II): initial phase of development and pilot study. Cantabria disability work group. Actas Esp Psiquiatr 2000, 28:77-87.
31. Lowe B, Decker O, Muller S, Brahler E, Schellberg D, Herzog W, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Medical Care 2008, 46:266-274. 10.1097/MLR.0b013e318160d093, 18388841.
32. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psych 1951, 16:297-34.
33. Muthén BO. Latent variable modeling in heterogeneous populations. Psychometrika 1989, 54:557-586.
34. Kano Y. Structural equation modeling for experimental data. Structural Equation Modeling: Present and Future 2001, 381-402. Scientific Software International, Lincolnwood, Cudeck R, Toit S, Sörbom D.
35. Hanley JA, McNeil BJ. A method of comparing areas under receiver operating characteristic curves defined from the same cases. Radilogy 1983, 148:839-843.
36. IBM IBM SPSS Statistics 19 2009, Chicago IL, IBM.
37. Arbuckle JL, Wothke W. IBM SPSS AMOS 18 2009, Smallwaters Corporation, Meadville PA.
38. Zimmerman M, Ruggero CJ, Chelminski I, Young D, Posternak MA, Friedman M, et al. Developing brief scales for use in clinical practice: the reliability and validity of single-item self-report measures of depression symptom severity, psychosocial impairment due to depression, and quality of life. J Clin Psychiatry 2006, 67:1536-1541. 10.4088/JCP.v67n1007, 17107244.
39. Mitchell AJ, Coyne JC. Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies. Br J Gen Pract 2007, 57:144-151. 2034175, 17263931.
40. Watson LC, Zimmerman S, Cohen LW, Dominik R. Practical depression screening in residential care/assisted living: five methods compared with gold standard diagnoses. Am J Geriatr Psychiatry 2009, 17:556-564. 10.1097/JGP.0b013e31819b891c, 19554670.
41. Henkel V, Mergl R, Coyne JC, Kohnen R, Möller HJ, Hegerl U. Screening for depression in primary care: will one or two items suffice?. Eur Arch Psychiatry Clin Neurosci 2004, 254:215-223.
42. Donker T, Van Straten A, Marks IM, Cuijpers P. A quick web screening questionnaire for common mental disorders: development and validation. J Med Internet Res 2009, 11:e19. 10.2196/jmir.1134, 2763401, 19632977.